CSTL – Castle Biosciences Inc
Investors holding1
Combined shares53,035
Combined reported value$1.9M
CSTL chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Paul Tudor Jones narrow view | 0.01 | Added 266.7% | 53,035 | $1.9M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Added 266.7% | 53,035 | 0.01 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 93.5% | 14,462 | 0.02 |
| Q1 2026 | Paul Tudor Jones narrow view | Added 33.4% | 222,982 | 0.01 |
| Q4 2025 | Paul Tudor Jones narrow view | Added 95.7% | 167,178 | 0.02 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Added 266.7% | 53,035 | 0.01 |
| Q1 2026 | Paul Tudor Jones narrow view | Added 33.4% | 222,982 | 0.01 |
| Q4 2025 | Paul Tudor Jones narrow view | Added 95.7% | 167,178 | 0.02 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 93.5% | 14,462 | 0.02 |
History
2 peakQ3 2026: 1 tracked investors
20192026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Paul Tudor Jones | 53.0K | 14.5K | 223.0K | 167.2K | 85.4K | 76.5K | 171.4K | 70.1K |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).